Tania Szado

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology · 2011 · 2.4K citations

Medicine, Oncology, Pharmacology +16

Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca ²⁺ release and apoptosis

Tania Szado, Veerle Vanderheyden, Jan B. Parys et al. · Proceedings of the National Academy of Sciences · 2008 · 253 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Javier Cortés, P. Fumoleau, Giulia Bianchi et al. · Journal of Clinical Oncology · 2012 · 246 citations · Full text

Medicine, Oncology, Pharmacology +17

Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer

Giampaolo Bianchini, Astrid Kiermaier, Giulia Bianchi et al. · Breast Cancer Research · 2017 · 129 citations · Full text

Medicine, Oncology, Pharmacology +17

Augmented Contractile Response of Vascular Smooth Muscle in a Diabetic Mouse Model

Elena B. Okon, Tania Szado, Ismail Laher et al. · Journal of Vascular Research · 2003 · 105 citations

Medicine, Pharmacology, Physiology +17